Traumatic Brain Injuries Assessment Market Analysis

  • Report ID: 6689
  • Published Date: Nov 14, 2024
  • Report Format: PDF, PPT

Traumatic Brain Injuries Assessment Market Analysis

Product (Screening devices, Monitoring devices)

Screening devices segment is expected to dominate around 80.4% traumatic brain injuries assessment market share by the end of 2037. Developments in technology have led to the progress of more accurate and sophisticated screening devices for TBIs. Innovations such as handheld devices, portable neuroimaging tools, and advanced algorithms improve the ability to detect and assess brain injuries more effectively and drive the traumatic brain injuries assessment market for these devices which leads to segmental growth.

For example, in March 2022, Swift Medical Inc. announced the Swift Ray 1, an advanced hardware device that can be connected wirelessly to a smartphone camera. This device transforms the field of wound care expertise by capturing comprehensive clinical data, which greatly enhances the assessment and monitoring of the treatment of wounds and other skin conditions. The Swift Ray 1 is designed to be compact, and easily suitable in the palm of a clinician or patient's hand, permitting portable and convenient medical imaging.

Screening devices empower healthcare professionals to access powerful imaging capabilities at any place, from the hospital setting to the ease of a patient's home. This can be attributed to the minimally invasive nature of these devices and growing awareness and developments in healthcare facilities. Moreover, factors, such as better accuracy of these devices, growing patient preference for non-invasive procedures, and an increasing preference among physicians for brain disease progression monitoring, are projected to drive the growth of this segment throughout the forecast period.

End use (Hospitals, Diagnostic centers, Other end users)

The hospital segment is projected to have a faster-growing traumatic brain injuries assessment market share during the forecast period of 2025-2037. Hospitals are often the first point of care for TBI patients. Hospital admissions are also driven by the rising number of brain surgeries across the world. The rise in the number of hospitals improves access to progressive treatment and diagnostic facilities for TBIs by safeguarding timely and accurate assessment. This growth supports the availability of multidisciplinary teams and specialized care while improving patient results and driving traumatic brain injuries assessment market growth.

Our in-depth analysis of the global market includes the following segments:

Product

  • Screening devices
  • Monitoring devices

End use

  • Hospitals
  • Diagnostic centers
  • Other end users
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 6689
  • Published Date: Nov 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The traumatic brain injuries assessment market size was USD 3.4 billion in 2024.

The global traumatic brain injuries assessment market size was USD 3.4 billion in 2024 and is likely to reach USD 8.2 billion by the end of 2037, expanding at a CAGR of 7.7% over the forecast period, i.e., 2025-2037.

Abbott Laboratories, BrainScope, Inc., Oculogica, Raumedic AG, Koninklijke Philips N.V., InfraScan, Inc., and Natus Medical, Inc. are some key players in the market.

The screening devices segment is expected to hold a leading share during the forecast period.

North America is projected to offer lucrative prospects with a share of 47.5% in 2037.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample